SCHEMBL681519

SCHEMBL681519

CC[C@H](C)CBr

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3722018 1.00
SCHEMBL115533 1.00
SCHEMBL6718961 0.96
SCHEMBL10729300 0.96
SCHEMBL3116714 0.96
SCHEMBL8699529 0.87
SCHEMBL11689836 0.83 TSHR (0.30)
Thiocyanic Acid SCHEMBL9214638 0.83
SCHEMBL1821872 0.79
SCHEMBL11691842 0.78 LMNA (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 222 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4341246-A1 A FACILE AND ODOR-FREE APPROACH TO CONVERT SULFONYL UREA DERIVATIVES TO CHALCOGENIDE SULFONYL UREA DERIVATIVES The United States of America, as represented by The Secretary, Department of Health and Human Services (US) 2024-03-27 EP claimed
WO-2022245627-A1 A FACILE AND ODOR-FREE APPROACH TO CONVERT SULFONYL UREA DERIVATIVES TO CHALCOGENIDE SULFONYL UREA DERIVATIVES THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2022-11-24 WO claimed
CN-109761991-B Material with long-life room-temperature phosphorescence phenomenon, preparation method and application 南京邮电大学 2021-08-10 CN claimed
JP-1029330-A None JP disclosed
JP-63175095-A None JP disclosed
JP-1128950-A None JP disclosed
JP-6306087-A None JP disclosed
EP-4707277-A1 NOVEL HETEROCYCLIC AMINE DERIVATIVES AND PHARMACEUTICAL COMPOSITION COMPRISING SAME Daewoong Pharmaceutical Co., Ltd. (KR) 2026-03-11 EP disclosed
US-20250263367-A1 A FACILE AND ODOR-FREE APPROACH TO CONVERT SULFONYL UREA DERIVATIVES TO CHALCOGENIDE SULFONYL UREA DERIVATIVES THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES 2025-08-21 US disclosed
WO-2024228580-A1 NOVEL HETEROCYCLIC AMINE DERIVATIVES AND PHARMACEUTICAL COMPOSITION COMPRISING SAME 주식회사 대웅제약 2024-11-07 WO disclosed
US-11970432-B2 Process for preparing 2-methyl-N-(2′-methylbutyl)butanamide SHIN-ETSU CHEMICAL CO., LTD. (JP) 2024-04-30 US disclosed
EP-0256303-A2 Liquid crystal compounds having fluorine-containing core POLAROID CORPORATION (US) 1988-02-24 EP disclosed
EP-0255236-A2 Fluorine-containing chiral smectic liquid crystals MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1988-02-03 EP disclosed
EP-0242716-A1 Liquid-crystalline pyridine derivatives F. HOFFMANN-LA ROCHE AG (CH) 1987-10-28 EP disclosed
WO-1987005018-A2 OPTICALLY ACTIVE COMPOUNDS MERCK Patent Gesellschaft mit beschränkter Haftung (DE) 1987-08-27 WO disclosed
EP-0220297-A1 NITROGEN-CONTAINING HETEROCYCLES. MERCK PATENT GMBH (DE) 1987-05-06 EP disclosed
WO-1986006373-A1 NITROGEN-CONTAINING HETEROCYCLES MERCK Patent Gesellschaft mit beschränkter Haftung (DE) 1986-11-06 WO disclosed
EP-0164814-A2 Liquid crystalline ester compounds and mixtures thereof Chisso Corporation (JP) 1985-12-18 EP disclosed
US-3996260-A Alkoxybenzylidene-aminobenzonitriles RCA CORPORATION (US) 1976-12-07 US disclosed
US-3975286-A Low voltage actuated field effect liquid crystals compositions and method of synthesis BECKMAN INSTRUMENTS, INC. (US) 1976-08-17 US disclosed